Biomonitoring of occupational exposure to phthalates: A systematic review.


Journal

International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843

Informations de publication

Date de publication:
08 2020
Historique:
received: 15 01 2020
revised: 08 04 2020
accepted: 22 04 2020
pubmed: 14 7 2020
medline: 4 6 2021
entrez: 14 7 2020
Statut: ppublish

Résumé

Phthalates, a group of ubiquitous industrial chemicals, have been widely used in occupational settings, mainly as plasticizers in a variety of applications. Occupational exposure to different phthalates has been studied in several occupational settings using human biomonitoring (HBM). To provide a comprehensive review of the available literature on occupational exposure to phthalates assessed using HBM and to determine future data needs on the topic as part of the HBM4EU project. A systematic search was carried out in the databases of Pubmed, Scopus, and Web of Science for articles published between 2000 and September 4, 2019 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 22 studies on the occupational HBM of phthalates was considered suitable for review. Among the reviewed studies, 19 (86%) focused on DEHP, an old phthalate that is now subject to authorization and planned to be restricted in the EU. Concentrations of MEHHP, one of its metabolites, varied up to 13-fold between studies and across sectors when comparing extreme geometric means, ranging from 11.6 (similar to the general populations) to 151 μg/g creatinine. Only 2 studies focused on newer phthalates such as DiNP and DPHP. Concerning the geographical distribution, 10 studies were performed in Europe (including 6 in Slovakia), 8 in Asia, and 4 in North America, but this distribution is not a good reflection of phthalate production and usage levels worldwide. Most HBM studies were performed in the context of PVC product manufacturing. Future studies should focus on: i) a more uniform approach to sampling timing to facilitate comparisons between studies; ii) newer phthalates; and iii) old phthalates in waste management or recycling. Our findings highlight the lack of recent occupational HBM studies on both old and new phthalate exposure in European countries and the need for a harmonized approach. Considering the important policy actions taken in Europe regarding phthalates, it seems relevant to evaluate the impact of these actions on exposure levels and health risks for workers.

Identifiants

pubmed: 32659708
pii: S1438-4639(20)30031-6
doi: 10.1016/j.ijheh.2020.113548
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Phthalic Acids 0
phthalic acid 6O7F7IX66E

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113548

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.

Auteurs

Nadine Fréry (N)

Public Health France (SpFrance), 12 rue du Val d'Osne, 94415, Saint Maurice Cedex, France. Electronic address: nadine.frery@santepubliquefrance.fr.

Tiina Santonen (T)

Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032, Työterveyslaitos, Finland.

Simo P Porras (SP)

Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032, Työterveyslaitos, Finland.

Aleksandra Fucic (A)

Institute for Medical Research and Occupational Health (IMROH), Ksaverska cesta 2, 10000, Zagreb, Croatia.

Veruscka Leso (V)

Department of Public Health (DPH), University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

Radia Bousoumah (R)

French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), 1 rue du Morvan, 54519, Vandœuvre-Lès-Nancy, France.

Radu Corneliu Duca (RC)

National Health Laboratory (LNS), Department of Health Protection, Unit Environmental Hygiene and Human Biological Monitoring, 1 rue Louis Rech, 3555, Dudelange, Luxembourg.

Mounia El Yamani (M)

Public Health France (SpFrance), 12 rue du Val d'Osne, 94415, Saint Maurice Cedex, France.

Marike Kolossa-Gehring (M)

Federal Environment Agency (UBA, Umweltbundesamt), Bismarckpl. 1, 14193, Berlin, Germany.

Sophie Ndaw (S)

French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), 1 rue du Morvan, 54519, Vandœuvre-Lès-Nancy, France.

Susana Viegas (S)

NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa and Health & Technology Research Center, ESTeSL-IPL, Avenida Padre Cruz, 1600-560, Lisbon, Portugal.

Ivo Iavicoli (I)

Department of Public Health (DPH), University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH